Quantification of SARS-CoV-2 Monoclonal IgG Mass Fraction by Isotope Dilution Mass Spectrometry

Overview

Journal Anal Bioanal Chem

Specialty Chemistry

Date 2024 Mar 1

PMID 38427100

Authors

G Martos

M Bedu

R D Josephs

S Westwood

R I Wielgosz

Affiliations

Soon will be listed here.

Abstract

The availability of serology assays to measure antibodies against the SARS coronavirus 2 (SARS-CoV-2) expanded rapidly during the Covid-19 pandemic. The interchangeable use of such assays to monitor disease progression and immune protection requires their standardization, for which suitably characterized monoclonal antibody materials can be useful. The methods, based on isotope dilution mass spectrometry, to value assign the mass fraction of such a material in solution within the context of an international interlaboratory comparison study (CCQM-P216) are described. The mass fraction in solution of a humanized IgG monoclonal antibody (mAb) against the SARS-CoV-2 Spike glycoprotein in the study sample has been value assigned through a combination of liquid chromatography, isotope dilution mass spectrometry (LC-ID-MS) methods and size exclusion chromatography with UV detection (SEC-UV). The former were developed for the quantification of amino acids and proteotypic peptides as surrogate analytes of the mAb while the latter was applied for the determination of the relative monomeric mass fraction. High-resolution mass spectrometry (hrMS) allowed the molecular weight evaluation and ruled out the presence of significant impurities. Method trueness was assessed using a subclass homologous IgG1 material value assigned by amino acid analysis. The assigned mass fraction of monomeric SARS-CoV-2 IgG in solution was 390 ± 16 mg/g. The associated expanded uncertainty originated mainly from acid hydrolysis variability and Trypsin/Lys-C digestion variability and efficiency.

Citing Articles

Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review.

Doring S, Weller M, Reinders Y, Konthur Z, Jaeger C Antibodies (Basel). 2025; 14(1.

PMID: 39846611 PMC: 11755444. DOI: 10.3390/antib14010003.

References

Gundlapalli A, Salerno R, Brooks J, Averhoff F, Petersen L, McDonald L . SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response. Open Forum Infect Dis. 2021; 8(1):ofaa555. PMC: 7717402. DOI: 10.1093/ofid/ofaa555. View

Landry J, Ke Y, Yu G, Zhu X . Measuring affinity constants of 1450 monoclonal antibodies to peptide targets with a microarray-based label-free assay platform. J Immunol Methods. 2014; 417:86-96. PMC: 4339518. DOI: 10.1016/j.jim.2014.12.011. View

Burkitt W, Pritchard C, Arsene C, Henrion A, Bunk D, OConnor G . Toward Système International d'Unité-traceable protein quantification: from amino acids to proteins. Anal Biochem. 2008; 376(2):242-51. DOI: 10.1016/j.ab.2008.02.010. View

Kappe C, Damm M . Parallel microwave chemistry in silicon carbide microtiter platforms: a review. Mol Divers. 2011; 16(1):5-25. DOI: 10.1007/s11030-011-9346-x. View

Fountoulakis M, Lahm H . Hydrolysis and amino acid composition of proteins. J Chromatogr A. 1999; 826(2):109-34. DOI: 10.1016/s0021-9673(98)00721-3. View

Arsene C, Ohlendorf R, Burkitt W, Pritchard C, Henrion A, OConnor G . Protein quantification by isotope dilution mass spectrometry of proteolytic fragments: cleavage rate and accuracy. Anal Chem. 2008; 80(11):4154-60. DOI: 10.1021/ac7024738. View

Nouri-Nigjeh E, Zhang M, Ji T, Yu H, An B, Duan X . Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein. Anal Chem. 2014; 86(7):3575-84. PMC: 3982980. DOI: 10.1021/ac5001477. View

Maes K, Smolders I, Michotte Y, Van Eeckhaut A . Strategies to reduce aspecific adsorption of peptides and proteins in liquid chromatography-mass spectrometry based bioanalyses: an overview. J Chromatogr A. 2014; 1358:1-13. DOI: 10.1016/j.chroma.2014.06.072. View

Westwood S, Choteau T, Daireaux A, Josephs R, Wielgosz R . Mass balance method for the SI value assignment of the purity of organic compounds. Anal Chem. 2013; 85(6):3118-26. DOI: 10.1021/ac303329k. View

10.

Proc J, Kuzyk M, Hardie D, Yang J, Smith D, Jackson A . A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J Proteome Res. 2010; 9(10):5422-37. PMC: 2996461. DOI: 10.1021/pr100656u. View

11.

Leon I, Schwammle V, Jensen O, Sprenger R . Quantitative assessment of in-solution digestion efficiency identifies optimal protocols for unbiased protein analysis. Mol Cell Proteomics. 2013; 12(10):2992-3005. PMC: 3790306. DOI: 10.1074/mcp.M112.025585. View

12.

Maity H, Wei A, Chen E, Haidar J, Srivastava A, Goldstein J . Comparison of predicted extinction coefficients of monoclonal antibodies with experimental values as measured by the Edelhoch method. Int J Biol Macromol. 2015; 77:260-5. DOI: 10.1016/j.ijbiomac.2015.03.027. View

13.

Henrion A, Arsene C, Liebl M, OConnor G . Label-free quantification of host cell protein impurity in recombinant hemoglobin materials. Anal Bioanal Chem. 2023; 416(2):387-396. PMC: 10761545. DOI: 10.1007/s00216-023-05024-8. View

14.

Mouchahoir T, Schiel J . Development of an LC-MS/MS peptide mapping protocol for the NISTmAb. Anal Bioanal Chem. 2018; 410(8):2111-2126. PMC: 5830484. DOI: 10.1007/s00216-018-0848-6. View

15.

Prior S, Metcalfe C, Hufton S, Wadhwa M, Schneider C, Burns C . Maintaining 'standards' for biosimilar monoclonal antibodies. Nat Biotechnol. 2021; 39(3):276-280. DOI: 10.1038/s41587-021-00848-0. View

16.

Furlong M, Ouyang Z, Wu S, Tamura J, Olah T, Tymiak A . A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies. Biomed Chromatogr. 2012; 26(8):1024-32. DOI: 10.1002/bmc.2759. View

17.

Ladwig P, Barnidge D, Snyder M, Katzmann J, Murray D . Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry. Clin Chem. 2014; 60(8):1080-8. DOI: 10.1373/clinchem.2014.222208. View

18.

Freeman J, Conklin J . Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material. J Virol Methods. 2021; 300:114430. PMC: 8667347. DOI: 10.1016/j.jviromet.2021.114430. View

19.

Elledge S, Zhou X, Byrnes J, Martinko A, Lui I, Pance K . Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. Nat Biotechnol. 2021; 39(8):928-935. PMC: 8355051. DOI: 10.1038/s41587-021-00878-8. View

20.

Tian L, Elsheikh E, Patrone P, Kearsley A, Gaigalas A, Inwood S . Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19. Int J Mol Sci. 2021; 22(5). PMC: 7962843. DOI: 10.3390/ijms22052723. View